Melanoma sentinel node biopsy and prediction models for relapse and overall survival

Gene Expression Profiling of Paraffin-Embedded Primary Melanoma Using the DASL Assay Identifies Increased Osteopontin Expression as Predictive of Reduced Relapse-Free Survival

(2009) C. Conway et al.   CLINICAL CANCER RESEARCH

A Multimarker Prognostic Assay for Primary Cutaneous Melanoma

(2009) M. Kashani-Sabet et al.   CLINICAL CANCER RESEARCH

Validation of a Nomogram to Predict the Presence of Sentinel Lymph Node Metastases in Melanoma

(2008) Antonio Piñero et al.   ANNALS OF SURGICAL ONCOLOGY

Osteopontin: Role in immune regulation and stress responses

(2008) Kathryn X. Wang et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Sentinel lymph node status is the most important prognostic factor for thick (≥ 4 mm) melanomas

(2008) Ralf Gutzmer et al.   JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT

Prognostic factors of cutaneous melanoma in relation to metastasis at the sentinel lymph node: A case-controlled study

(2008) Leonardo Sartore et al.   International Journal of Surgery